Alimera Sciences: 2Q Earnings Snapshot
Jul. 30, 2018
ALPHARETTA, Ga. (AP) _ Alimera Sciences Inc. (ALIM) on Monday reported a loss of $4 million in its second quarter.
On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 6 cents.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 6 cents per share.
The eye drug developer posted revenue of $10.9 million in the period.
In the final minutes of trading on Monday, the company's shares hit $1.11. A year ago, they were trading at $1.47.